Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Dirk Elewaut
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
77
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor-spokesperson
01 January 2024 → 31 December 2027
Deep molecular and functional phenotyping of γδ T cells in spondyloarthritis
Funding: Research Foundation - Flanders (FWO)
01 January 2023 → 31 December 2026
Mechanoinflammation in arthritic disease
Funding: Research Foundation - Flanders (FWO)
As
Promotor
15 August 2014 → 14 February 2016
A proof of concept study for a novel mechanism of action to combat osteoporosis by inhibiting osteoclastogenesis
Funding: Regional and community funding: Industrial Research Fund
22 July 2010 → 30 June 2016
A unique imaging system combining flow cytometry and confocal microscopy
Funding: Research Foundation - Flanders (FWO)
08 November 2018 → 07 November 2019
BeSSTT: Belgian Sjörren's Syndrome transition trial
Funding: Funding by bilateral agreement (private and foundations)
01 January 2011 → 31 December 2014
Characterization of novel antibody targets in rheumatoid arthritis
Funding: Research Foundation - Flanders (FWO)
01 November 2021 → 31 October 2025
Deciphering the functional phenotype of ?d T cells in spondyloarthritis.
Fellow: Zuzanna Łukasik
Funding: Research Foundation - Flanders (FWO)
01 October 2021 → 31 October 2021
Deciphering the functional phenotype of γδ T cells in spondyloarthritis.
Funding: Regional and community funding: Special Research Fund
01 January 2024 → 31 December 2025
Deep molecular and functional phenotyping of γδ T cells in spondyloarthritis
Funding: Regional and community funding: Special Research Fund
01 January 2023 → 31 December 2026
DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.
Funding: European funding: framework programme
01 January 2017 → 31 October 2022
Dynamic modulation of disease progression in chronic gut and joint inflammation in spondyloarthritides
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2018
Dynamic visualization of TCR-induced NKT cell arrest and anergy induction in vivo
Funding: Research Foundation - Flanders (FWO)
01 March 2012 → 31 August 2012
Functional profiling and therapeutic tolerization of macrophages in type 1 diabetes
Funding: European funding: framework programme
15 April 2012 → 30 June 2014
GDF15-mAbs: development assay and evaluation therapy
Funding: Regional and community funding: Industrial Research Fund
01 January 2019 → 31 December 2022
How T cell autoreactivity develops in early rheumatoid arthritis: the smoking gun hypothesis
Funding: Research Foundation - Flanders (FWO)
01 October 2020 → 17 September 2023
Identification and characterization of type 2 NKT ligands induced by endoplasmic reticulum stress in cancer immunotherapy
Fellow: Srinath Govindarajan
Funding: Research Foundation - Flanders (FWO)
01 January 2019 → 31 December 2019
Identifying the functional outcome of different antigen presenting cells for NKT cell activation in the liver.
Fellow: Djoere Gaublomme
Funding: Research Foundation - Flanders (FWO)
01 October 2012 → 30 September 2016
Immune therapy in MM: can INKT cells be targeted?
Funding: Funding by bilateral agreement (private and foundations)
15 July 2016 → 14 January 2018
Inhibiting pathogenic bone loss in arthritis: a proof of concept study
Funding: Regional and community funding: Industrial Research Fund
01 January 2012 → 31 October 2017
Investigation of novel targets for therapeutic intervention in chronic gut and joint inflammation in spondyloarthritides
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2016
in vivo visualization of NKT cell-mediated anti-tumor activity
Funding: Funding by bilateral agreement (private and foundations)
01 April 2012 → 31 December 2017
IUAPVII/96/Elewaut
Funding: Federal funding: various
01 October 2023 → 30 September 2027
Mechanosensing via adhesion G protein-coupled receptors (aGPCR) in musculoskeletal disease
Funding: Regional and community funding: Special Research Fund
01 October 2016 → 30 September 2020
Modulation of host-microbial interplay in spondyloarthritis
Fellows: Céline Mortier
Funding: Research Foundation - Flanders (FWO)
01 January 2009 → 31 December 2014
Molecular elucidation of polarized cytokine responses induced by structural changes in glycolipid antigenten presented by CD1d.
Funding: Research Foundation - Flanders (FWO)
01 February 2013 → 30 April 2016
Monitoring innate immunity in arthritis and mucosal inflammation
Funding: European funding: framework programme
01 November 2024 → 31 October 2028
MOnocyte-directed NAnotherapy for Resolution of CHronic arthritis (MONARCH).
Fellow: Andrea Cere
Funding: Research Foundation - Flanders (FWO)
01 January 2018 → 31 December 2021
Preservation and repair of the joint: meeting the osteoarthritis challenge
Funding: Research Foundation - Flanders (FWO)
01 June 2015 → 31 May 2017
Purchase and installation of a bedding dump system for the SPF animalarium MRB2
Funding: Regional and community funding: Special Research Fund
01 January 2009 → 31 December 2014
Regulation of emigration invariant killer T cells in the thymus.
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 30 September 2013
Regulation of emigration of invariant natural killer T cells from the thymus
Fellow: Michael Drennan
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2014 → 31 December 2014
Rehabilitation in Axial spondyloarthritis
Funding: Funding by bilateral agreement (private and foundations)
01 October 2008 → 01 October 2009
Research into cellular processes and their therapeutic potential, involved in impaired chondrocyte metabolism in the pathogenesis of OA.
Funding: Regional and community funding: Special Research Fund
01 January 2012 → 31 December 2014
Research into the role of GDF-15 in rheumatological disorders in vivo
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2019
Role of biomechanical stress in inflammatory arthritis
Funding: Research Foundation - Flanders (FWO)
01 October 2015 → 30 September 2019
Role of biomechanical stress in inflammatory arthritis
Fellow: Karlijn Debusschere
Funding: Research Foundation - Flanders (FWO)
01 January 2023 → 31 December 2026
Role of endogenous NKT ligands induced by Endoplasmic Reticulum stress in NASH-driven hepatocellular carcinoma
Funding: Funding by bilateral agreement (private and foundations)
01 October 2017 → 30 September 2020
Role of endoplasmic reticulum (ER) stress induced immunogenic lipids in cancer immunotherapy
Fellows: Srinath Govindarajan
Funding: Research Foundation - Flanders (FWO)
01 November 2020 → 31 October 2024
Role of group 2 innate lymphoid cells in knee ligament homeostasis during osteoarthritis
Fellow: Guillaume Planckaert
Funding: Research Foundation - Flanders (FWO)
01 January 2012 → 31 December 2016
Role of homeostasis of lymphoid structures in inflammation
Funding: Research Foundation - Flanders (FWO)
01 October 2014 → 30 September 2029
Role of innovative research tools as biomarkers to predict severe clinical complications in Systemic Sclerosis.
Fellows: Vanessa Smith
Funding: Research Foundation - Flanders (FWO)
01 October 2018 → 30 September 2022
Role of intestinal barrier dysfunction for the pathogenesis of spondyloarthritis
Fellow: Ann-Sophie De Craemer
Funding: Regional and community funding: Special Research Fund
06 October 2016 → 31 December 2017
Role of mechanical strain in spondyloarthritis: a proof of concept study
Funding: Funding by bilateral agreement (private and foundations)
01 October 2008 → 30 September 2012
Role of natural killer T cells in the pathophysiology and treatment of experimental arthritis
Fellow: Sandrine Aspeslagh
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2009 → 31 October 2011
Role of polarized analogues of alpha-galactosylceramide on the antiviral immune response during CMV infections
Funding: Regional and community funding: Special Research Fund
01 January 2014 → 31 December 2019
Role of the intestinal microbiome in spondyloarthritides
Funding: Research Foundation - Flanders (FWO)
01 November 2022 → 31 October 2026
Sjögren's syndrome pathophysiology investigating trial: the SSPIT concept
Fellow: Helena Achten
Funding: Research Foundation - Flanders (FWO)
01 October 2021 → 31 October 2022
Sjögren’s Syndrome Pathophysiology Investigating Trial: the SSPIT concept
Fellow: Helena Achten
Funding: Regional and community funding: Special Research Fund
01 October 2009 → 30 September 2013
Study of cellular mechanisms and their therapeutic potential, involved in the distorted chondrocyte metabolism during the development of osteoarthritis.
Fellow: Stijn Lambrecht
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2012 → 31 December 2017
Study of the impact of CYLD cleavage on lymphocyte function in vivo and its potential contribution to inflammatory and autoimmune disorders
Funding: Research Foundation - Flanders (FWO)
01 January 2011 → 31 December 2014
Study of the interaction of natural killer T cells and regulatory T cells in chronic inflammatory arthritis
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 30 November 2016
Study of the interactions of regulatory T cells in chronic inflammatory arthritis
Fellow: Koen Venken
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 March 2011 → 01 March 2013
T cell-mediated modulation of Th1/Th17 balances and its consequences on osteoclastogenesis in autoimmune arthritis
Funding: Federal funding: various
01 October 2012 → 30 September 2016
T cell receptor signaling pathways in autoimmune disease
Fellow: Elisabeth Gilis
Funding: Regional and community funding: Special Research Fund
01 October 2012 → 30 September 2015
T cell receptor signaling pathways in autoimmune disease: the in vivo role of CYLD cleavage
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 October 2012 → 30 September 2016
The role of biomechanical factors and hypoxia in the induction of chronic tendinitis in spondyloarthropathy.
Fellow: Katelijne De Wilde
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2019 → 31 December 2022
The role of innate-like T cells in combined gut-joint disease in spondyloarthritis
Funding: Research Foundation - Flanders (FWO)
01 October 2007 → 01 February 2011
The role of Ltab in the regulation of thymic emigration and peripheral homing of Vai NKT cells
Funding: Regional and community funding: Special Research Fund
01 October 2017 → 31 December 2021
The role of the gut microbiome in sarcopenia
Fellows: Anton De Spiegeleer
Funding: Research Foundation - Flanders (FWO)
01 October 2013 → 30 September 2017
Unraveling the role of S100-DAMPs in seronegative arthritis
Fellow: Karlijn Debusschere
Funding: Regional and community funding: Special Research Fund
01 October 2020 → 30 September 2023
Unravelling the molecular mechanisms of how mechanical force triggers inflammatory arthritis
Fellow: Eric Gracey
Funding: Research Foundation - Flanders (FWO)
01 January 2008 → 30 December 2013
Validation of a new mouse model of systemic sclerosis and study of the B cell as effector cell in the disease
Funding: Research Foundation - Flanders (FWO)
As
Copromotor
01 March 2009 → 28 February 2013
Advanced vaccines and pharmaceuticals targeted to macrophages via sialoadhesin
Funding: Regional and community funding: various
01 February 2007 → 31 January 2009
Cancer sciences xs47 r261 (code 8461)
Funding: European funding: various
04 January 2012 → 31 December 2017
DEVREPAIR: Paracrine and transcriptional control of cell differentiation in organ development and repair
Funding: Federal funding: various
01 May 2024 → 30 April 2028
FullPicture: Combining Spectral Flow Cytometry with High-Speed Cell Imaging to enable comprehensive profiling of plant and animal cells and their components in real time.
Funding: Research Foundation - Flanders (FWO)
01 January 2010 → 31 December 2015
Negative regulation of NF-kB in the pathophysiology of rheumatoid arthritis and systemic lupus erythermatosus
Funding: Research Foundation - Flanders (FWO)
01 January 2009 → 31 December 2010
Purchase of equipment supporting the sterile housekeeping of mice in the Central Animalarium of the faculty of Medicine and Health Sciences
Funding: Regional and community funding: Special Research Fund
01 November 2022 → 31 October 2026
Quorum Sensing Peptides in Sarcopenia: moving towards personalised therapies
Fellow: Liesbeth Crombez
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 31 October 2012
Relation between inflammation of the gut and arthritis in spondyloarthropathy: cellular mechanisms and therapeutical implications
Funding: Regional and community funding: Special Research Fund
01 January 2009 → 31 December 2014
Research into the role of small heat shock proteins and GDF-15 in the biology of cartilage cells and their involvement in the development of osteoarthritis.
Funding: Research Foundation - Flanders (FWO)
01 May 2022 → 30 April 2026
SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomics
Funding: Research Foundation - Flanders (FWO)
01 January 2012 → 31 December 2015
STRETCH: mechanotransduction in osteoimmunology: an innovative approach towards effective drug for rheumatic diseases
Funding: Regional and community funding: various
01 May 2020 → 30 April 2024
The BD FACS Symphony FACS cell sorter: the most advanced multiparameter fluorescence activated cell sorter that allows the identification and purification of rare cells for further functional characterization
Funding: Research Foundation - Flanders (FWO)
01 October 2022 → 31 December 2023
The Best Of Both Worlds: Nuclear Receptor Heterodimers To Battle Against Rheumatoid Arthritis.
Fellow: Lisa Koorneef
Funding: Research Foundation - Flanders (FWO)
01 November 2022 → 31 October 2027
The role of the RANKL/RANK/OPG pathway in the cross talk between synovial fibroblasts and synovial myeloid cells in erosive hand osteoarthritis.
Fellow: Tine Vanhaverbeke
Funding: Research Foundation - Flanders (FWO)
01 October 2021 → 31 October 2022
The role of the RANKL/RANK/OPG pathway in the cross talk between synovial fibroblasts and synovial myeloid cells in erosive hand osteoarthritis.
Fellow: Tine Vanhaverbeke
Funding: Regional and community funding: Special Research Fund